FDA launches new AI-powered system to track drug and vaccine side effects nationwide

NEWYou can now listen to Fox News articles! FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health effects linked to medicines, vaccines, cosmetics, animal food and other consumer products. The FDA Adverse Event Monitoring System … Read more

FDA warns Novo Nordisk over unreported potential Ozempic side effects

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects of the flagship diabetes drug, which is also prescribed for weight loss.  In the letter, dated March 5, the FDA cited three deaths among patients receiving … Read more

FDA finds little evidence that a generic drug can help people with autism

WASHINGTON — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that the drug showed great promise for people with autism. The agency said it approved leucovorin for children and adults with a genetic condition that … Read more

FDA approves new use of synthetic vitamin B9 — but not for autism symptoms

The Food and Drug Administration on Tuesday announced a new approved use for the drug leucovorin, a synthetic form of vitamin B9 that the Trump administration has touted as a treatment for autism symptoms. But the new approval is not for autism — it’s for cerebral folate deficiency, a rare neurological condition characterized by low … Read more

Trump administration’s embattled FDA vaccine chief is leaving — again

The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases. FDA Commissioner Marty Makary announced the news to FDA staff in an … Read more

Trump administration’s embattled FDA vaccine chief is leaving for the second time

WASHINGTON — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases. FDA Commissioner Marty Makary announced the news to FDA staff … Read more

Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressants

WASHINGTON — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to antidepressants about unproven pregnancy risks, The Associated Press has learned. Dr. Adam Urato, a maternal-fetal medicine specialist and critic of antidepressant safety, is pressing … Read more